Room sensors that show when crowded indoor air becomes an infection risk
TL;DR Airgauge puts low-cost sensors in OPD waiting rooms, TB centres, classrooms and offices. AI turns carbon dioxide, particle and headcount readings into a room risk band with a fix attached, like opening windows or thinning a queue. Hospitals and buildings pay per room per month. It measures ventilation, not germs.
India carried about a quarter of the world's tuberculosis burden in 2024, an estimated 27.1 lakh new cases[1]. TB and other airborne infections spread wherever people wait together, in OPD queues, chest clinics and classrooms. CSIR-CCMB scientists found viable coronavirus in hospital air, and detection went up as more infected people shared a room[2].
Yet hardly anyone measures these rooms. CPCB lists no indoor air quality standard[3].
Hospitals that do check rely on settle plates, which in one Telangana study took 24–48 hours for bacteria and seven days for fungi[4]. So fans and air conditioners run on habit, and nobody knows when a crowded room has quietly turned risky.
First, the regulatory bit - Airgauge does environmental monitoring of rooms, not people. It does not screen, diagnose or detect disease in anyone. Medical-device rules turn on use on humans[5], so it should sit outside them as long as outputs stay at room level, but do confirm with CDSCO. It claims no drop in infections until a study shows one.
Here's how it works. A wall unit reads carbon dioxide, fine particles, temperature, humidity and an anonymous door count, with no cameras anywhere. The software estimates how much of the room's air has already been breathed by someone else, using a peer-reviewed method[6], and shows green, amber or red with an instruction the facility team can act on. It learns each room's rhythm, so it warns you before the 11 a.m. rush.
The original version promised real-time detection of airborne pathogens. Today's real-time sensors can't identify species and struggle with viruses[7], and one big lab-equipment maker has discontinued its hospital air sampler[8]. Ventilation is what cheap sensors can measure reliably right now.
Patients, students and staff benefit but they don't pay. Private hospitals and clinic chains do, because their infection-control and facilities heads both care about air and neither has a number. Offices already buy indoor air monitors for certification and tenant comfort[9], which gives you volume while the hospital case gets proved. My rough estimate is ₹8,000–15,000 per unit plus ₹500–1,500 per room per month, since Indian rivals quote only on request.
Accredited carbon dioxide and particle monitors are already sold to Indian commercial buildings[9], so hardware isn't the hard part. The science linking carbon dioxide to transmission risk goes back to 2003[6]. Since the pandemic WHO has published a ventilation roadmap for healthcare buildings[10], and in September 2026 a US air-biosurveillance startup raised US$25M for airborne biosurveillance[11], which tells you investors now take indoor air seriously.
The closest figure covers all air quality monitoring, outdoor included. One market research firm puts India at US$180.51M in 2025, growing 5.95% a year[12], about ₹1,746 Cr.
Outdoor monitors are the biggest share and no source splits out indoor or healthcare use, so treat this as a neighbour. If you want a real estimate then count hospitals, OPD rooms and schools and multiply by a monthly room fee.
Indoor air-monitor brands already sell to Indian commercial buildings, hospitals included, on certification rather than infection risk[9]. A lab-grade air sampler that fed samples to PCR sold at US$4,995 and has been withdrawn[8], which is a lesson in what buyers wouldn't keep paying for. Air-biosurveillance startups sequence pathogens from air for governments, the expensive end of the problem. A Kerala tech firm launched a hospital air monitor in 2025, and its detection claims are its own.
Nobody sells room-level ventilation risk with actions to Indian clinics. That's the gap.
| Difficulty | Moderate (42/100) |
| Starting capital | ₹1.68–3.1 Cr |
| Time to launch | 4–6 months |
Selling is the hardest part. No Indian rule forces anyone to buy, and every hospital has a microbiologist who will poke holes in your evidence. Cheap sensors also drift in dusty, humid rooms, and an alert system that cries wolf gets ignored within weeks, so calibration, alert design and field service matter far more than clever models.
Probably no medical licence, because Airgauge monitors rooms and not people. The radio module is the part that does need approval.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI claim anything about infections. Airgauge measures ventilation, and nobody should read a green room as proof that no one will get sick.
Want to work out the AI layer for Airgauge? Talk to Yash →
Here's what can go south -
I think there's a real business in making ventilation visible, as long as you sell it honestly. It suits a founder with building-services or hospital-operations experience who can sell to facility managers. If you want to build a germ detector then expect years of research.
First find out whether NABH gives credit for air monitoring - a yes would change the economics.
My estimate is ₹1.68–3.1 Cr to launch, covering sensor hardware, the software and early pilots with hospitals and schools. The kit breaks it down line by line.
You'll need WPC approval for the radio module. A room monitor most likely falls outside medical device rules, but confirm that with CDSCO.
Yes, and plenty of markets have stricter indoor air rules than India, which can help sales. Check local radio and product safety approvals first.
The free Airgauge validation kit has the line-by-line capital breakdown, the effort scoring, the radio and device-rules checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for hospitals and schools, and 5 assumptions to test. Download the kit →
Thinking of building Airgauge or something like it? The make-or-break bit is selling room monitoring to hospitals when no rule requires it, and that's the kind of problem I help founders crack. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.